ArticleNPJ digital medicine2025
Deep learning-based mobile application for efficient eyelid tumor recognition in clinical images.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Fungal recognition in vaginal discharge using deep learning analysis of mobile device-acquired microscopic images.Frontiers in cellular and infection microbiology · 2026Article
- Advances in the application of artificial intelligence in ophthalmic education and clinical training.Frontiers in medicine · 2025Review
- Artificial intelligence in oculoplastics: Novel applications and future prospects.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Early detection, regular monitoring of eyelid tumors and post-surgery recurrence monitoring are crucial for patients. However, frequent hospital visits are burdensome for patients with poor medical conditions. This study validates a novel deep learning-based mobile application, based on YOLOv5 and Efficient-Net v2-B architectures, for self-diagnosing eyelid tumors, enabling improved health support systems for such patients. 1195 preprocessed clinical ocular photographs and biopsy results were collected for model training. The best-performing model was chosen and converted into a smartphone-based application, then further evaluated based on external validation dataset, achieved 0.921 accuracy for triple classification outcomes (benign/malignant eyelid tumors or normal eye), generally superior to that of general physicians, resident doctors, and ophthalmology specialists. Intelligent Eyelid Tumor Screening application exhibited a straightforward detection process, user-friendly interface and treatment recommendation scheme, provides preliminary evidence for recognizing eyelid tumors and could be used by healthcare professionals, patients and caregivers for detection and monitoring purposes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.